Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion

OBJECTIVE: PF-06438179/GP1111 (PF-SZ-IFX) is an infliximab biosimilar. We evaluated the extended in-use physicochemical and biological stability of PF-SZ-IFX upon preparation for intravenous infusion. METHODS: Two batches of PF-SZ-IFX were reconstituted to a concentration of 10 mg/mL and subsequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vimpolsek, Maja, Gottar-Guillier, Marie, Rossy, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544699/
https://www.ncbi.nlm.nih.gov/pubmed/30810925
http://dx.doi.org/10.1007/s40268-019-0264-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544699/
https://www.ncbi.nlm.nih.gov/pubmed/30810925
http://dx.doi.org/10.1007/s40268-019-0264-1

Ejemplares similares